Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Qing-Feng Luo"'
Autor:
Shan Zhou, Fang-Ling Zhao, Shuang-Hu Wang, Yi-Ran Wang, Yun Hong, Quan Zhou, Pei-Wu Geng, Qing-Feng Luo, Jian-Ping Cai, Da-Peng Dai
Publikováno v:
Pharmaceutical Biology, Vol 61, Iss 1, Pp 356-361 (2023)
AbstractContext Poziotinib and vonoprazan are two drugs mainly metabolized by CYP3A4. However, the drug-drug interaction between them is unknown.Objective To study the interaction mechanism and pharmacokinetics of poziotinib on vonoprazan.Materials a
Externí odkaz:
https://doaj.org/article/79a4ba7b298642aaa32f83b48285d136
Autor:
Fang-Ling Zhao, Qing Zhang, Shuang-Hu Wang, Yun Hong, Shan Zhou, Quan Zhou, Pei-Wu Geng, Qing-Feng Luo, Jie-Fu Yang, Hao Chen, Jian-Ping Cai, Da-Peng Dai
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Cytochrome 2C9 (CYP2C9), one of the most important drug metabolic enzymes in the human hepatic P450 superfamily, is required for the metabolism of 15% of clinical drugs. Similar to other CYP2C family members, CYP2C9 gene has a high genetic polymorphi
Externí odkaz:
https://doaj.org/article/82e7e3b0ff074e13897a7243a48384c2
Autor:
Qiang-Qiang Jia, Qing-Feng Luo, Hao-Fei Ni, Chang-Yuan Su, Da-Wei Fu, Li-Yan Xie, Hai-Feng Lu
Publikováno v:
The Journal of Physical Chemistry C. 126:1552-1557
Publikováno v:
Materials Chemistry Frontiers.
Two tin-based organic–inorganic hybrid halides with a reversible dielectric switching response using halogen modulation.
Autor:
Yun Hong, Da-Peng Dai, Jian-Ping Cai, Shuang-Hu Wang, Yi-Ran Wang, Fang-Ling Zhao, Shan Zhou, Quan Zhou, Pei-Wu Geng, Yun-Fang Zhou, Xue Xu, Ji-Hua Shi, Qing-Feng Luo
Publikováno v:
Drug Design, Development and Therapy.
Yun Hong,1,* Da-Peng Dai,2,* Jian-Ping Cai,2 Shuang-Hu Wang,3 Yi-Ran Wang,1,4 Fang-Ling Zhao,2,4 Shan Zhou,2 Quan Zhou,3 Pei-Wu Geng,3 Yun-Fang Zhou,3 Xue Xu,1 Ji-Hua Shi,1 Qing-Feng Luo1 1Department of Gastroenterology, Beijing Hospital, Nat
Publikováno v:
Indian Journal of Pathology and Microbiology, Vol 56, Iss 3, Pp 190-195 (2013)
Background and Aim: The strategies of targeting valosin-containing protein (VCP) may have therapeutic potential for treating cancer metastasis. In this study, we aim to investigate the correlation of VCP protein expression in osteosarcoma (OS) tissue
Externí odkaz:
https://doaj.org/article/d9680b81884f4b33a60cd76bf263952b
Publikováno v:
Indian Journal of Pathology and Microbiology, Vol 55, Iss 2, Pp 163-169 (2012)
Background : Fatty acid synthase (FASN) is overexpressed in a variety of human cancers, and may be involved in cancer metastasis. Hence, the strategies targeted on FASN may have therapeutic potential for treating cancer metastasis. Objectives : The
Externí odkaz:
https://doaj.org/article/6c1f22e4030f4483b137376f6dee0fe7
Autor:
Ai Fen Peng, Qing Feng Luo, Xin Hua Long, Yong Shu, Zhi Li Liu, Yun Fei Zhou, Xiao Ping Zhu, Shan Hu Huang
Publikováno v:
Experimental and Therapeutic Medicine
Previous studies have suggested that Aurora-B may be involved in cancer metastasis. However, its role has been poorly evaluated in osteosarcoma (OS). The aim of this study was to investigate the correlation between Aurora-B expression and metastasis
Autor:
Rong Ping Zhou, Song Gao, Qing Feng Luo, Ai Fen Peng, Yang Zhou, Wen Zhao Chen, Guo Mei Zhang, Heng Wang, Tao Fang Wang, Zhi Li Liu, Xin Hua Long
Publikováno v:
International Journal of Molecular Medicine. 33:633-639
The activation of PI3K/Akt and the overexpression of fatty acid synthase (FASN) are frequently observed in human osteosarcoma (OS). In the present study, in order to investigate the possible association between the phosphorylation of Akt and FASN exp
Autor:
Qing-Feng Luo, Ai-Fen Peng, Song Gao, Yang Zhou, Hui‑Cai Wen, Zhi-li Liu, Guo Mei Zhang, Lin Zhang, Rong-Ping Zhou, Xin-Hua Long
Publikováno v:
Oncology Reports. 31:328-334
Lapatinib, an inhibitor of human epidermal growth factor receptor 2 (HER2) phosphorylation, has been reported to inhibit several types of tumors such as HER2-overexpressing breast cancer. However, the effect of lapatinib on the malignant phenotype of